LP

LB Pharmaceuticals Inc.

Biotechnology Healthcare New York, NY, United States LBRX (NGM)

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 1 clinical trial for the treatment of bipolar I depression; and in pr clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.

Stock Performance (90 Days)

Data through Dec 30, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has LB PHARMACEUTICALS INC had layoffs?
No layoff events have been recorded for LB PHARMACEUTICALS INC in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does LB PHARMACEUTICALS INC have?
LB PHARMACEUTICALS INC has approximately 16 employees.
What industry is LB PHARMACEUTICALS INC in?
LB PHARMACEUTICALS INC operates in the Biotechnology industry, within the Healthcare sector.
Is LB PHARMACEUTICALS INC a publicly traded company?
Yes, LB PHARMACEUTICALS INC is publicly traded under the ticker symbol LBRX on the NGM. The company has a market capitalization of approximately $0.54 billion.
Where is LB PHARMACEUTICALS INC headquartered?
LB PHARMACEUTICALS INC is headquartered in New York, NY, United States at One Pennsylvania Plaza, New York, NY 10119, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.